Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Patil

Showing results (591-600 of 611) with videos related to

Pageof 62
Sort By:
Nature Communications|July 4, 2018
CEACAM1 promotes CD8<sup>+</sup> T cell responses and improves control of a chronic viral infectionVishal Khairnar, Vikas Duhan, Ashwini M Patil, et al.
The American Journal of Surgical Pathology|February 3, 2021
A Distinctive Adnexal (Usually Paratubal) Neoplasm Often Associated With Peutz-Jeghers Syndrome and Characterized by STK11 Alterations (STK11 Adnexal Tumor): A Report of 22 CasesJennifer A Bennett, Robert H Young, Brooke E Howitt, et al.
International Journal of Cancer|November 9, 2021
The clinical utility and safety of short-course immune checkpoint inhibitors in multiple tumours-A real-world multicentric study from IndiaGeorge Abraham, Vanita Noronha, Senthil Rajappa, et al.
Mini Reviews in Medicinal Chemistry|January 20, 2024
An <i>In Silico</i> Approach to Exploring the Antinociceptive Biological Activities of Linalool and its MetabolitesPablo Rayff da Silva, Natalia Diniz Nunes Pazos, Jéssica Cabral de Andrade, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 11, 2021
Targeting RNA editing of antizyme inhibitor 1: A potential oligonucleotide-based antisense therapy for cancerDaryl Jin Tai Tay, Yangyang Song, Boya Peng, et al.
Cancer Medicine|October 31, 2020
COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatmentAnant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik, et al.
The Lancet Regional Health. Southeast Asia|August 19, 2024
Uniqueness of lung cancer in Southeast AsiaVanita Noronha, Atul Budukh, Pankaj Chaturvedi, et al.
JNCI Cancer Spectrum|July 27, 2024
Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative advanced gastric cancersAnant Ramaswamy, Prabhat Bhargava, Biswajit Dubashi, et al.
Journal of Cheminformatics|September 7, 2021
Computational Applications in Secondary Metabolite Discovery (CAiSMD): an online workshopFidele Ntie-Kang, Kiran K Telukunta, Serge A T Fobofou, et al.
Journal of Assisted Reproduction and Genetics|June 29, 2020
Installing oncofertility programs for common cancers in limited resource settings (Repro-Can-OPEN Study): An extrapolation during the global crisis of Coronavirus (COVID-19) pandemicM Salama, L Ataman-Millhouse, M Braham, et al.
Pageof 62

Showing results (591-600 of 611) with videos related to

Sort By:
Pageof 62
Nature Communications|July 4, 2018
CEACAM1 promotes CD8<sup>+</sup> T cell responses and improves control of a chronic viral infectionVishal Khairnar, Vikas Duhan, Ashwini M Patil, et al.
The American Journal of Surgical Pathology|February 3, 2021
A Distinctive Adnexal (Usually Paratubal) Neoplasm Often Associated With Peutz-Jeghers Syndrome and Characterized by STK11 Alterations (STK11 Adnexal Tumor): A Report of 22 CasesJennifer A Bennett, Robert H Young, Brooke E Howitt, et al.
International Journal of Cancer|November 9, 2021
The clinical utility and safety of short-course immune checkpoint inhibitors in multiple tumours-A real-world multicentric study from IndiaGeorge Abraham, Vanita Noronha, Senthil Rajappa, et al.
Mini Reviews in Medicinal Chemistry|January 20, 2024
An <i>In Silico</i> Approach to Exploring the Antinociceptive Biological Activities of Linalool and its MetabolitesPablo Rayff da Silva, Natalia Diniz Nunes Pazos, Jéssica Cabral de Andrade, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 11, 2021
Targeting RNA editing of antizyme inhibitor 1: A potential oligonucleotide-based antisense therapy for cancerDaryl Jin Tai Tay, Yangyang Song, Boya Peng, et al.
Cancer Medicine|October 31, 2020
COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatmentAnant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik, et al.
The Lancet Regional Health. Southeast Asia|August 19, 2024
Uniqueness of lung cancer in Southeast AsiaVanita Noronha, Atul Budukh, Pankaj Chaturvedi, et al.
JNCI Cancer Spectrum|July 27, 2024
Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative advanced gastric cancersAnant Ramaswamy, Prabhat Bhargava, Biswajit Dubashi, et al.
Journal of Cheminformatics|September 7, 2021
Computational Applications in Secondary Metabolite Discovery (CAiSMD): an online workshopFidele Ntie-Kang, Kiran K Telukunta, Serge A T Fobofou, et al.
Journal of Assisted Reproduction and Genetics|June 29, 2020
Installing oncofertility programs for common cancers in limited resource settings (Repro-Can-OPEN Study): An extrapolation during the global crisis of Coronavirus (COVID-19) pandemicM Salama, L Ataman-Millhouse, M Braham, et al.
Pageof 62